Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Krystal Biotech Insider Sold Shares Worth $8,982,986, According to a Recent SEC Filing

Krystal Biotech Insider Sold Shares Worth $8,982,986, According to a Recent SEC Filing

MT newswireMT newswire2026/09/08 07:51
03:51 AM EDT, 09/08/2026 (MT Newswires) -- Suma Krishnan, 10% Owner, Director, President, Research and Development, on September 04, 2026, sold 25,000 shares in Krystal Biotech (KRYS) for $8,982,986. Following the Form 4 filing with the SEC, Krishnan has control over a total of 1,493,155 common shares of the company, with 1,302,145 shares held directly and 191,010 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1711279/000129871126000009/xslF345X05/wk-form4_1788563746.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!